Eculizumab is a long-acting humanized monoclonal antibody that targets against complement C5. It stops the cleavage of C5 into C5a and C5b and hence inhibits the deployment of the terminal complement system such as forming of MAC.
Hi, Welcome to icliniq.com. I have read the query, and I can understand your concern. As a newly diagnosed patient, you will have questions and concerns about your condition.
Hello, Welcome to icliniq.com. NMOSD (neuromyelitis optica spectrum disorder) is a challenging illness, and pregnancy decisions are especially complex.
Hello, Welcome to icliniq.com. I have read your query and can understand your concern.
Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.
